Development and the need for implementation of a health-related quality of life measurement strategy for patients with soft tissue sarcoma undergoing preoperative radiotherapy
The newly developed HRQoL tool is currently undergoing validation within the SCOPES trial (NTC04425967), evaluating HRQoL outcomes in patients undergoing standard versus hypofractionated radiotherapy. This tool will lead to better understanding the full impact of treatment on sarcoma patients and hopefully, ultimately improve their HRQoL. Moreover, it provides a standardized framework that can be utilized across studies, facilitating the comparison of HRQoL data and enabling more consistent and comprehensive insights into patient outcomes.
Authors
- Astrid N. Scholten (ORCID: https://orcid.org/0000-0002-3242-4989)
- Marta Fiocco (ORCID: https://orcid.org/0000-0001-5588-0277)
- Yvonne Schrage (ORCID: https://orcid.org/0000-0001-7065-514X)
- Lisette M. Wiltink (ORCID: https://orcid.org/0000-0003-3483-4241)
- Jules Lansu (ORCID: https://orcid.org/0000-0003-1396-1647)
- Rick L. Haas (ORCID: https://orcid.org/0000-0003-4834-4331)
- Winette T.A. van der Graaf (ORCID: https://orcid.org/0000-0001-7549-3338)
- Olga Husson (ORCID: https://orcid.org/0000-0002-1387-8686)
- Winan J. van Houdt
- G F Foppele
Institutions
- Leiden University (NL)
- Leiden University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Oncode Institute (NL)
- Haga Hospital (NL)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-04-30
- DOI
- https://doi.org/10.2340/1651-226x.2025.43110
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52